Monash IVF Group (ASX:MVF) shares rose nearly 15% in recent Wednesday trade following Tuesday's steep fall after the company disclosed its second embryo transfer error.
RBC Capital Markets analyst Craig Wong-Pan said the mistake carries risks of higher reputational damage and possible market share losses, according to a Tuesday report from The Australian.